Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients. [electronic resource]
Producer: 19990610Description: 111-20 p. digitalISSN:- 0168-8227
- Anticholesteremic Agents -- therapeutic use
- Apolipoproteins B -- blood
- Blood Glucose -- metabolism
- Body Mass Index
- Cholesterol -- blood
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Diabetes Mellitus, Type 2 -- blood
- Female
- Humans
- Hypercholesterolemia -- blood
- Lipid Peroxidation
- Lipid Peroxides -- blood
- Lipoproteins -- blood
- Lipoproteins, IDL
- Lipoproteins, LDL -- blood
- Male
- Middle Aged
- Phospholipids -- blood
- Pravastatin -- therapeutic use
- Probucol -- therapeutic use
- Regression Analysis
- Smoking
- Time Factors
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.